Skip to main content
. 2021 Oct 8;3(6):1074–1081. doi: 10.1016/j.xkme.2021.08.008

Figure 2.

Figure 2

Percentage of steroid-treated patients with immune checkpoint inhibitors (ICI)-induced acute interstitial nephritis (AIN) that achieved full or partial remission. Studies with ≥10 patients with ICI-AIN treated with steroids were included. The typical steroid courses used in these studies include a starting dose of 40-100 mg/day (0.5-1 mg/kg/day) tapered over 4-12 weeks.6,11,12,14,19